top of page
gradientForSurfBreak.png

Item List

Cision PR Newsire
Strados Labs forms collaboration with Boehringer Ingelheim for its Idiopathic Pulmonary Fibrosis (IPF) Pilot Study

Strados Labs today announced a collaboration with Boehringer Ingelheim to remotely monitor patients using its FDA-cleared pulmonary wearable device in an upcoming idiopathic pulmonary fibrosis (IPF) pilot study. In Boehringer Ingelheim's pilot study, the Strados RESP Biosensor will be used to monitor cough and crackles in IPF patients at home aiming to accelerate the development of much needed new therapies for people living with IPF.

Recent Posts

Portfolio Company

Carlsmed.png

Matterworks Announces Updates to Leadership Team ...

PR Newswire

Portfolio Company

Carlsmed.png

Mother Goose Health Partners with Nest Collaborative and Introduce its Ground Br ...

CIO Review

Portfolio Company

Carlsmed.png

UptimeHealth Announces Acquisition of Dental Whale, Including its Subsidiaries D ...

Businesswire

surf break copy_edited_edited.jpg
surbreak-19.png
WM360_logo-18.png
bottom of page